Improving outcomes for people diagnosed with breast cancer

BCAL Diagnostics is developing a blood-based screening tool for the monitoring and detection of breast cancer.

 

Breast cancer is the most common cancer among women globally according to the World Cancer Research Fund International, accounting for 25% of all cancer cases and 15% of all cancer deaths in women. More than 2 million new cases of breast cancer are registered annually (20,000 in Australia and 250,000 in the USA).

 

Blood lipids and lipoproteins have been implicated in cancer development and growth through insulin resistance, inflammation, oxidative stress pathways, and signalling molecules in cancer cells.

 

The large-scale, prospective study “Breast Cancer Associated Lipids Found in Plasma” is aiming to develop a sensitive and specific diagnostic screening test based on lipids found in blood. 

 

Speak to one of our Study Coordinators for further information: info@bcaldiagnostics.com